Call for Abstracts
Call for Abstracts is closed.
Abstract guidelines for VAS●COG 2013:
Research work should be original and innovative. Work can be presented prior to the VAS●COG 2013, but MUST include new information
Abstracts must be submitted electronically through the Conference website
Abstracts can be submitted under the following themes
|
![]() |
- Abstracts will be accepted in English only
- Abstracts should not exceed 300 words in length (not including title, author(s) and affiliations)
- Tables, images and graphics may be included and each will count as 50 words
- Abstracts will be uploaded as a word document to the website, formatted as per the Abstract template - click here to download the Abstract Template
- There is no fee for submitting an abstract
- There is no limit to the number of abstracts you may submit (however an individual may not be offered more than 2 oral presentations)
- An international panel of reviewers will review all abstracts anonymously
- All Abstracts accepted by the Scientific Committee will be published for the confernce.
- Financial Disclosure information needs to be completed for EACH co-author at the time of submission through the online abstract submission form, however, information can be provided by the submitting author
Authors of submitted abstracts will be informed of the Abstract Review Committee’s decision by April 26, 2013. Presenting Authors of Accepted Abstracts are required to register by May 3, 2013 for the Congress and are responsible for their own travel arrangements. This permits presenters to take advantage of reduced Early registration fees.
Important Dates:
Call for Abstracts Open February 2013
Call for Abstracts Closes March 22, 2013 Extended to April 1, 2013
Notification of Acceptance Sent April 29, 2013
Presenting Author Registration Deadline May 3, 2013
Disclosure
The Scientific Committee for the The 6th International Society of Vascular Behavioural and Cognitive Disorders (VAS●COG) Congress has mandated that the presenter and authors must identify any financial interest in products or processes involved in their research. This disclosure is required upon submitting abstracts and it part of the submission process.
If you have questions regarding the submission of abstracts please e-mail This e-mail address is being protected from spambots. You need JavaScript enabled to view it



